Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 1,231 | 286 | 1,762 | 2,574 | 2,590 |
| Gross Profit | 1,231 | 286 | 1,762 | 2,574 | 2,590 |
| Operating Expenses | 35,205 | 38,425 | 31,647 | 29,764 | 27,687 |
| Operating Income | -33,974 | -38,139 | -29,885 | -27,190 | -25,097 |
| Other Income | -922 | 33 | 229 | 610 | 4,306 |
| Pre-tax Income | -34,895 | -38,105 | -29,657 | -26,581 | -20,791 |
| Net Income Continuous | -34,895 | -38,105 | -29,657 | -26,581 | -20,791 |
| Net Income | $-34,895 | $-38,105 | $-29,657 | $-26,581 | $-20,791 |
| EPS Basic Total Ops | -12.91 | -15.62 | -12.91 | -12.01 | -9.61 |
| EPS Basic Continuous Ops | -12.80 | -15.49 | -12.86 | -12.15 | -9.66 |
| EPS Diluted Total Ops | -12.91 | -15.62 | -12.91 | -12.01 | -9.61 |
| EPS Diluted Continuous Ops | -12.80 | -15.49 | -12.86 | -12.09 | -9.66 |
| EBITDA(a) | $-33,510 | $-37,678 | $-29,427 | $-26,785 | $-24,813 |